Módos Orsolya, Váradi Melinda, Dér Bálint, Keszthelyi Attila, Szűcs Miklós, Reis Henning, Nyirády Péter, Szarvas Tibor
1 Semmelweis Egyetem, Általános Orvostudományi Kar, Urológiai Klinika és Uroonkológiai Centrum Budapest, Üllői út 78/B, 1082 Magyarország.
2 Dr. Senckenberg Patológiai Intézet, Frankfurti Egyetemi Kórház Frankfurt, Németország Magyarország.
Orv Hetil. 2023 Apr 23;164(16):602-609. doi: 10.1556/650.2023.32754.
Urachal carcinoma is a rare malignancy that is uniquely associated with the field of urology. Urachal carcinoma is mostly diagnosed in urological care centers due to its most frequently presenting symptom that is hematuria. Currently available diagnostic and therapeutic knowledge is solely based on case reports and single center series, while no prospective clinical studies are carried out due to the modest number of patients. These circumstances have made creating professional guidelines challenging, hence the treatment of urachal carcinoma is commonly based on individual clinical decisions. In this review, we summarize the epidemiology, diagnostic modalities, prognosis as well as local and systemic therapeutic approaches of urachal carcinoma. Furthermore, we aim to draw conclusions from this knowledge base that may guide clinical decision-making. Finally, we highlight some of the novel therapeutic strategies that hold the potential to improve urachal carcinoma patients' prognosis and quality of life. Orv Hetil. 2023; 164(16): 602-609.
